VKTX Stock Analysis: Buy, Sell, or Hold?
VKTX - Viking Therapeutics, Inc
$31.47
-0.23 (-0.73%)
▼
5d:
-0.35%
30d:
-11.23%
90d:
+3.21%
HOLD
MODERATE Confidence
Analysis Updated: May 13, 2026 12:00 AM ET
Earnings: Apr 29, 2026
0d
Smart Money Accumulation
VKTX is down 3.3% this week, but smart money is accumulating calls. Top strike: $35 2026-07-17 with 1,783 OI. Call ratio: 87% View Scanner →
Strength: 5.3/10
Get Alerted When VKTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
7 traders called VKTX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VKTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VKTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VKTX is currently trading at $31.47, which is considered slightly low relative to its 30-day fair value range of $31.48 to $34.74.
Technical Outlook: Technically, VKTX is showing sideways momentum. Immediate support is located at $28.82, while resistance sits at $32.67.
Market Sentiment: VKTX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $92.33 (+191.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VKTX is showing sideways momentum. Immediate support is located at $28.82, while resistance sits at $32.67.
Market Sentiment: VKTX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $92.33 (+191.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$31.48 -
$34.74
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 191.3% below Wall St target ($92.33)
Trading Range Analysis
30-Day Trading Range
$31.48 -
$34.74
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$28.82
Resistance Level
$32.67
Current Trend
Sideways
Technical data as of
May 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.98
Wall Street Target
$92.33
(+191.3%)
Share & Embed Analysis
Last updated: May 14, 2026 11:41 AM ET
Data refreshes hourly during market hours. Next update: 12:41 PM
Data refreshes hourly during market hours. Next update: 12:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VKTX showing a specific setup today?
Insider Activity (6 Months)
1
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Neil William Aubuchon
BUY
4475 shares
2026-03-10
Brian Lian
SELL
233409 shares
2026-01-05
Greg Zante
SELL
57661 shares
2026-01-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$26 | 56 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$130 | 54 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 55 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$104 | 50 HOLD |
